Great Point Partners LLC Intra Cellular Therapies, Inc. Transaction History

Great Point Partners LLC

  • $152 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $2.54 Million - $2.98 Million
39,393 Added 35.62%
150,000 $10.4 Million
Q4 2023

Feb 14, 2024
SELL
$46.37 - $73.65 $5.3 Million - $8.43 Million
-114,393 Reduced 50.84%
110,607 $7.92 Million
Q3 2023

Nov 14, 2023
BUY
$52.09 - $64.1 $11.7 Million - $14.4 Million
225,000 New
225,000 $11.7 Million
Q1 2023

May 15, 2023
BUY
$43.8 - $56.99 $3.08 Million - $4.01 Million
70,371 New
70,371 $3.81 Million

Others Institutions Holding ITCI

# of Institutions
416
Shares Held
88.5M
Call Options Held
284K
Put Options Held
105K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $12.1B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email